Xilio Therapeutics, Inc. (XLO) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $154.69M | +117.6% |
| 2024 | $71.08M | +16.7% |
| 2023 | $60.93M | -56.2% |
| 2022 | $139.16M | -36.2% |
| 2021 | $218.06M | +500.4% |
| 2020 | $36.32M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $154.69M | +117.6% |
| 2024 | $71.08M | +16.7% |
| 2023 | $60.93M | -56.2% |
| 2022 | $139.16M | -36.2% |
| 2021 | $218.06M | +500.4% |
| 2020 | $36.32M | — |